These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19834827)

  • 1. Statins use and female lung cancer risk in Taiwan.
    Lai SW; Liao KF; Lin CL; Sung FC; Cheng YH
    Libyan J Med; 2012 Dec; 7(1):1-3. PubMed ID: 23272648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convincing evidence from controlled and uncontrolled studies on the lipid-lowering effect of a statin.
    Higgins J
    Cochrane Database Syst Rev; 2012 Dec; 2012(12):ED000049. PubMed ID: 23361645
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapidly Occurring Statin-Associated Muscle Symptoms With Rosuvastatin.
    Güven AT
    Am J Ther; 2023 Sep-Oct 01; 30(5):e486-e487. PubMed ID: 37713705
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in Gut Microbiota After Statin Administration: A New Candidate Mechanism for Statin-Associated New-Onset Type 2 Diabetes.
    Sakuma I
    Arterioscler Thromb Vasc Biol; 2024 Feb; 44(2):488-490. PubMed ID: 38152889
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid management in patients with type 2 diabetes and effects of gender-affirming therapy.
    Stringer F; Cooke R; MacIsaac R; Teng J
    Intern Med J; 2024 Jul; 54(7):1241-1242. PubMed ID: 39013772
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia.
    Park JS; Kim YJ; Choi JY; Kim YN; Hong TJ; Kim DS; Kim KY; Jeong MH; Chae JK; Oh SK; Seong IW
    Korean J Intern Med; 2010 Mar; 25(1):27-35. PubMed ID: 20195400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populations.
    Zhang L; Zhang S; Yu Y; Jiang H; Ge J
    Herz; 2020 Sep; 45(6):594-602. PubMed ID: 30483816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials.
    Takagi H; Niwa M; Mizuno Y; Yamamoto H; Goto SN; Umemoto T
    Heart Vessels; 2014 May; 29(3):287-99. PubMed ID: 23644555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atorvastatin or rosuvastatin? Select from the perspective of evidence-based medicine].
    Gogolashvili NG
    Kardiologiia; 2012; 52(7):84-92. PubMed ID: 22839720
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER).
    Nicholls SJ; Brandrup-Wognsen G; Palmer M; Barter PJ
    Am J Cardiol; 2010 Jan; 105(1):69-76. PubMed ID: 20102893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes.
    Mori Y; Kuriyama G; Tanaka T; Tajima N
    Endocrine; 2009 Dec; 36(3):412-8. PubMed ID: 19834827
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.
    Faergeman O; Hill L; Windler E; Wiklund O; Asmar R; Duffield E; Sosef F;
    Cardiology; 2008; 111(4):219-28. PubMed ID: 18434729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
    Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC
    Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
    Jones PH; Davidson MH; Stein EA; Bays HE; McKenney JM; Miller E; Cain VA; Blasetto JW;
    Am J Cardiol; 2003 Jul; 92(2):152-60. PubMed ID: 12860216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between rosuvastatin and atorvastatin in lipid-lowering action and effect on glucose metabolism in Japanese hypercholesterolemic patients with concurrent diabetes. Lipid-lowering with highly potent statins in hyperlipidemia with type 2 diabetes patients (LISTEN) study –.
    Ogawa H; Matsui K; Saito Y; Sugiyama S; Jinnouchi H; Sugawara M; Masuda I; Mori H; Waki M; Yoshiyama M; Watada H
    Circ J; 2014; 78(10):2512-5. PubMed ID: 25186922
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.